BioSpace News Archive

Evelo Biosciences, Inc., a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic effects, announced that it has entered into a loan and security agreement for up to $45 million with K2 HealthVentures, a healthcare investment firm.

hematologists and multiple myeloma patients in the UK will have access to Dutch developed diagnostic test MMprofilerTM with SKY92 algorithm through the diagnostic service provided by Everything Genetic Ltd. SkylineDx, the diagnostics company that developed the test, announced its collaboration with the UK based provider of a genetic testing service.

Bioz, Inc., a Silicon Valley AI data company for life science research and recipient of the prestigious Gartner Cool Vendor award, is excited to announce the expansion of its Bioz Badges program to further increase the ROI of life science product marketing.

Eurofins Scientific, a world leader in biopharmaceutical testing acquired Amatsigroup SAS to support Eurofins’ extensive drug development platform.

Eurofins Scientific, a world leader in biopharmaceutical testing acquired Alphora Research Inc. to support Eurofins’ extensive drug development platform.

MorphoSys AG will publish its first six months’ 2019 results on August 6, 2019 at 10:00pm CEST.

A combination of Opdivo and Yervoy hit the primary endpoint in NSCLC patients with PD-L1 expression. Opdivo and chemotherapy did not demonstrate efficacy in patients regardless of PD-L1 expression.

Ipsen, a global specialty-driven biopharmaceutical group, announced financial results for the first half of 2019.

Zambon, a multinational pharmaceutical company that focuses on innovation and development with the aim to improve the quality of people’s health and patients’ lives, announces the acquisition of Breath Therapeutics and its subsidiaries for € 140 million

Italian pharma company purchases Breath Therapeutics for up to €500 million, with €140 million up front